News | EP Lab | September 23, 2015

Societies Release New Guideline for Treating Supraventricular Tachycardia

Includes guidelines for diagnosis, referrals

guideline, treating supraventricular tachycardia, ACC, AHA, HRS

September 23, 2015 — A new guideline aimed at helping clinicians treat patients with supraventricular tachycardia, or a rapid heart rate, was released Sept. 23 by the American College of Cardiology, American Heart Association and Heart Rhythm Society.

Supraventricular tachycardia is common, with a prevalence of 2.29 per 1,000 persons in the general population. Those who have supraventricular tachycardia without any cardiovascular disease are usually younger compared to those who have cardiovascular disease. Women have twice the risk of developing the condition compared to men, and individuals over the age of 65 have five times the risk compared to younger individuals. Supraventricular tachycardia can impact quality of life depending on frequency, duration and whether symptoms occur not only when exercising but also while at rest. 

A diagnosis of supraventricular tachycardia is often made in the emergency department. A 12-lead electrocardiogram during tachycardia and sinus rhythm may help to determine the cause of tachycardia.

“The overall goal of the guideline is to provide clinicians with the tools needed to successfully diagnose and treat patients with supraventricular tachycardia upon presentation in the inpatient or outpatient setting,” said Richard L. Page, M.D., FACC, FAHA, FHRS, chair of the department of medicine at the University of Wisconsin and chair of the writing committee. “This includes quick diagnosis and treatment, making any necessary referrals to cardiology and electrophysiology specialists, discussion and collaboration with the patient, and the prescription of appropriate treatment.”

The guideline also aims to aid clinicians to help patients differentiate between supraventricular tachycardia and other disorders, such as panic attack, chest pain, and shortness of breath and syncope or near syncope— or a loss of consciousness due to a drop in blood pressure— that may cause similar symptoms.

The complete 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia, was jointly published online in the Journal of the American College of Cardiology, Circulation, and HeartRhythm.

It is important to note that while atrial fibrillation is a supraventricular tachycardia, the term does not usually refer to atrial fibrillation. This guideline is for the management of all types of supraventricular tachycardia other than atrial fibrillation. Atrial fibrillation is addressed in the 2014 ACC/AHA/HRS Guideline for the Management of Atrial Fibrillation.

For more information: www.acc.org, www.heart.org, www.hrsonline.org

Related Content

Livongo Launches Applied Health Signals Product Category
News | Cardiac Diagnostics | November 30, 2018
Healthcare technology company Livongo recently announced the launch of its Applied Health Signals product category,...
HHS Releases Second Edition of Physical Activity Guidelines for Americans. #AHA2018 #AHA18
News | Cardiac Diagnostics | November 14, 2018
The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines...
ACC and AHA Release Updated Cholesterol Guidelines for 2018. #AHA18 #AHA2018
Feature | Cardiac Diagnostics | November 13, 2018
November 13, 2018 — New cholesterol guidelines from the American Heart Association (AHA) and the American College of
AMI READMITS Score Predicts Heart Attack Patients at High Readmission Risk
News | Cardiac Diagnostics | October 09, 2018
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those...
Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Cardiac Diagnostics | September 21, 2018
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers...
Weight Loss Drug Does Not Increase Cardiovascular Events
News | Cardiac Diagnostics | August 31, 2018
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI...
Acarix Presents CADScor System at ESC 2018
News | Cardiac Diagnostics | August 27, 2018
Acarix AB’s ultra-sensitive acoustic CADScor System for coronary artery disease risk assessment will be on display at...
NIH Ending Funding for Moderate Alcohol and Cardiovascular Health Trial
News | Cardiac Diagnostics | August 24, 2018
The National Institutes of Health announced in June it plans to end funding to the Moderate Alcohol and Cardiovascular...
Study Shows Multiple Benefits of Patient-to-Patient Connectivity in Familial Chylomicronemia Syndrome
News | Cardiac Diagnostics | August 07, 2018
Akcea Therapeutics Inc., an affiliate of Ionis Pharmaceuticals Inc., announced the publication of results from the...
Being Overweight May Change Young Adults' Heart Structure, Function
News | Cardiac Diagnostics | August 03, 2018
Even as a young adult, being overweight may cause higher blood pressure and thicken heart muscle, setting the stage for...
Overlay Init